Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2022
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Amanda Peppercorn, MD
GlaxoSmithKline
Disclosure(s): GlaxoSmithKline: Employee, Stocks/Bonds
Poster(s):
304 - Viral resistance analysis in the COMET-PEAK study: sotrovimab treatment in participants with mild-to-moderate COVID-19
Thursday, October 20, 2022
12:15 PM – 1:30 PM
US ET
1150 - Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab
Friday, October 21, 2022
12:15 PM – 1:30 PM
US ET
1154 - Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19
Friday, October 21, 2022
12:15 PM – 1:30 PM
US ET
.png)
.png)